Gsk Share Discussion Threads

[ragonesi89] 30/8/2017 09:48

how much was paid to prefered shareholders in 2016?

[philanderer] 30/8/2017 08:33

30th aug Liberum buy tp 1900p

reiterates

[ny boy] 30/8/2017 08:26

Buy those sub 1500p dips Sir!

[loafofbread] 30/8/2017 08:24

If that's the same Tim McCarthy who ruined Alyzme I would be more than suspect.

[tradermichael] 29/8/2017 15:12

Success certainly doesn't seem to be factored into the share price by the looks of it.

[romeike] 29/8/2017 14:52

On the other hand the trial results flop or approval is denied based on tiny trial sizes used and you lose 80% or more of your capital.

[top tips] 29/8/2017 11:44

IMMUPHARMA (IMM)

Potential blockbuster Lupuzor Phase III results due Q1 2018.

Tim McCarthy (IMM's Chairman) 14/3/2017:

"There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug."

4 min 40 sec.

[philanderer] 29/8/2017 10:08

Best to sit back and do nothing until he actually blows something up I suppose.

Morning everyone.

[mip55] 29/8/2017 09:27

London stocks fell in early trade on Tuesday as investors were rattled by geopolitical tensions after North Korea launched a missile over Japan.

[montyhedge] 29/8/2017 09:26

The correction as started, 10% down coming. My view.

[tradermichael] 29/8/2017 09:24

Whole market down - any info on the 'fall'?

[philanderer] 28/8/2017 23:54

'Electroceuticals: the 'bonkers' gamble that could pay off for GlaxoSmithKline'


In need of fresh ideas, the drugmaker is banking on implantable devices capable of altering electrical impulses in the body

[ny boy] 25/8/2017 08:20

Monty if he had any sense would have added sub 1500p

Resistance 1540p, positive..if we can close above there.

[philanderer] 24/8/2017 19:51

GSK, Propeller expand digital health collaboration

[romeike] 24/8/2017 14:13

FDA decision on Shingrix should be relatively soon I would hope. Based on strong clinical trials likely approval in the US, and thereafter the EU, would be fantastic news for GSK and patients.

[alphorn] 24/8/2017 13:31

Rolled bullish GSK positions forward to March; a bit more option income.

[philanderer] 24/8/2017 13:24

'GSK Consumer Healthcare targets emerging market business growth with new facility'

[badtime] 24/8/2017 12:15

Monty on holiday this week?

[grahamite2] 24/8/2017 09:49

Troubled AstraZeneca
blue-chip GlaxoSmithKline

LOL!

[philanderer] 24/8/2017 09:42

24th aug Jefferies buy tp 1750p cut from 1900p

[ny boy] 24/8/2017 08:22

Let's get this back to 1700p +

[philanderer] 23/8/2017 21:27

Telegraph market report:

"....Healthcare giants were the biggest beneficiaries from the renewed tax reform hopes hinting that Mr Trump could push through some of his agenda. Troubled pharma firm AstraZeneca nudged up 61p to £44.95 while blue-chip rival GlaxoSmithKline gained 13p to £15.17."

[philanderer] 23/8/2017 21:10

Good overview..


'Are Glaxo's Successful New Drugs Enough to Drive Growth?'

[romeike] 23/8/2017 11:39

Between this baby and Shire you're on a winner, nice rise to come I am sure

[ny boy] 23/8/2017 09:49

especially to an overseas predator with the old blighty £ slumping